Hybrid Bio
PrivateCompany Overview
Hybrid Bio is a biotechnology company developing a myeloid cell therapy platform designed to overcome limitations in immuno-oncology treatments for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hybrid Bio Comparables
Compare Hybrid Bio with similar companies based on industry and business-model similarity.
No public comparables are available for Hybrid Bio. Request access to learn about comparables coverage.
Request accessHybrid Bio Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Headcount grew 133% QoQ (from 3 to 7 employees)
- Jan 5, 2026
Headcount grew 100% QoQ (from 3 to 6 employees)
Hybrid Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hybrid Bio's valuation, stock price, and market status.
Is Hybrid Bio a public or private company?
Hybrid Bio is a private company.
What is the current stock price of Hybrid Bio?
Hybrid Bio is a private company with no public stock price. Caplight tracks Hybrid Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Hybrid Bio worth (valuation)?
Valuation information for Hybrid Bio is not publicly available.
Can I buy Hybrid Bio stock?
Hybrid Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hybrid Bio's last funding round?
Funding round information for Hybrid Bio is not publicly available.
Who are the main investors in Hybrid Bio?
Investor information for Hybrid Bio is not publicly disclosed.
Will Hybrid Bio IPO soon?
No public IPO plans have been announced for Hybrid Bio.
How can I track Hybrid Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hybrid Bio's secondary market activity and sign up for updates.